• Herbalife reaffirmed Q3 2026 guidance for net sales growth of 0.5% to 4.5% year over year.
• Adjusted EBITDA forecast set at 160-180; CapEx expected at 15-25.
• On a constant-currency basis, net sales growth seen at 1.5% to 5.5%; adjusted EBITDA at 165-185.
• Full-year 2026 outlook maintained for net sales growth of 2.5% to 5.5%; adjusted EBITDA of 670-690.
• FY 2025 net sales were 5.04 billion; adjusted EBITDA was 657.6 million; Q3 2025 net sales were 1.27 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Herbalife Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260831893738) on August 31, 2026, and is solely responsible for the information contained therein.